Trial intelligence / Profile preview

THERAKOS CELLEX Photopheresis System for Early Stage CTCL

NCT05680558Phase 2Recruiting

Sponsor
Columbia University
Start
May 2021
Primary completion
Mar 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of methoxsalen in mycosis fungoides (MF), sponsored by Columbia University. Started May 2021; status: recruiting.

02

Drugs

methoxsalen
03

Conditions

mycosis fungoides (MF)

Beyond the preview

Go deeper on NCT05680558.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05680558.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call